 | • レポートコード：MRC2-11QY14357 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は予防喘息薬のグローバル市場について調査・分析したレポートです。種類別（ソマトスタチン類似体、標的療法、化学療法）市場規模、用途別（病院、クリニック、腫瘍学センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別予防喘息薬の競争状況、市場シェア ・世界の予防喘息薬市場：種類別市場規模 2015年-2020年（ソマトスタチン類似体、標的療法、化学療法） ・世界の予防喘息薬市場：種類別市場規模予測 2021年-2026年（ソマトスタチン類似体、標的療法、化学療法） ・世界の予防喘息薬市場：用途別市場規模 2015年-2020年（病院、クリニック、腫瘍学センター） ・世界の予防喘息薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、腫瘍学センター） ・北米の予防喘息薬市場分析：米国、カナダ ・ヨーロッパの予防喘息薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの予防喘息薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の予防喘息薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの予防喘息薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Xiaflex、Novartis AG、Roche、Molecular Insight Pharmaceuticals、Callisto Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Drugs for asthma attacks are bronchodilators. The products include pills, potions, inhalers and sprays. The effect is bronchiectasis, which can relieve asthma symptoms quickly and help prevent asthma attacks. This kind of medicine works well and is quite safe. But be careful not to overuse it. The main side effect is heartbeat. Commonly used are salbutamol (Salbutamol), terbutaline (Terbutaline) and so on.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Preventive Asthma Drug in US$ by the following Product Segments: Somatostatin Analogs, Targeted Therapy, Chemotherapy
Company profiles are primarily based on public domain information including company
Xiaflex
Novartis AG
Roche
Molecular Insight pharmaceuticals
Callisto Pharmaceuticals
Market Analysis and Insights: Global Preventive Asthma Drug Market
The global Preventive Asthma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Preventive Asthma Drug Scope and Market Size
Preventive Asthma Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preventive Asthma Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Preventive Asthma Drug market is segmented into
Somatostatin Analogs
Targeted Therapy
Chemotherapy
Segment by Application, the Preventive Asthma Drug market is segmented into
Hospital
Clinics
Oncology Centres
Regional and Country-level Analysis
The Preventive Asthma Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Preventive Asthma Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Preventive Asthma Drug Market Share Analysis
Preventive Asthma Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Preventive Asthma Drug business, the date to enter into the Preventive Asthma Drug market, Preventive Asthma Drug product introduction, recent developments, etc.
The major vendors covered:
Xiaflex
Novartis AG
Roche
Molecular Insight Pharmaceuticals
Callisto Pharmaceuticals
…
1 Study Coverage
1.1 Preventive Asthma Drug Product Introduction
1.2 Market Segments
1.3 Key Preventive Asthma Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Preventive Asthma Drug Market Size Growth Rate by Type
1.4.2 Somatostatin Analogs
1.4.3 Targeted Therapy
1.4.4 Chemotherapy
1.5 Market by Application
1.5.1 Global Preventive Asthma Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Oncology Centres
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Preventive Asthma Drug Market Size, Estimates and Forecasts
2.1.1 Global Preventive Asthma Drug Revenue 2015-2026
2.1.2 Global Preventive Asthma Drug Sales 2015-2026
2.2 Global Preventive Asthma Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Preventive Asthma Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Preventive Asthma Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Preventive Asthma Drug Competitor Landscape by Players
3.1 Preventive Asthma Drug Sales by Manufacturers
3.1.1 Preventive Asthma Drug Sales by Manufacturers (2015-2020)
3.1.2 Preventive Asthma Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Preventive Asthma Drug Revenue by Manufacturers
3.2.1 Preventive Asthma Drug Revenue by Manufacturers (2015-2020)
3.2.2 Preventive Asthma Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Preventive Asthma Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Preventive Asthma Drug Revenue in 2019
3.2.5 Global Preventive Asthma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Preventive Asthma Drug Price by Manufacturers
3.4 Preventive Asthma Drug Manufacturing Base Distribution, Product Types
3.4.1 Preventive Asthma Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Preventive Asthma Drug Product Type
3.4.3 Date of International Manufacturers Enter into Preventive Asthma Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Preventive Asthma Drug Market Size by Type (2015-2020)
4.1.1 Global Preventive Asthma Drug Sales by Type (2015-2020)
4.1.2 Global Preventive Asthma Drug Revenue by Type (2015-2020)
4.1.3 Preventive Asthma Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Preventive Asthma Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Preventive Asthma Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Preventive Asthma Drug Revenue Forecast by Type (2021-2026)
4.2.3 Preventive Asthma Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Preventive Asthma Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Preventive Asthma Drug Market Size by Application (2015-2020)
5.1.1 Global Preventive Asthma Drug Sales by Application (2015-2020)
5.1.2 Global Preventive Asthma Drug Revenue by Application (2015-2020)
5.1.3 Preventive Asthma Drug Price by Application (2015-2020)
5.2 Preventive Asthma Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Preventive Asthma Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Preventive Asthma Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Preventive Asthma Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Preventive Asthma Drug by Country
6.1.1 North America Preventive Asthma Drug Sales by Country
6.1.2 North America Preventive Asthma Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Preventive Asthma Drug Market Facts & Figures by Type
6.3 North America Preventive Asthma Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Preventive Asthma Drug by Country
7.1.1 Europe Preventive Asthma Drug Sales by Country
7.1.2 Europe Preventive Asthma Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Preventive Asthma Drug Market Facts & Figures by Type
7.3 Europe Preventive Asthma Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Preventive Asthma Drug by Region
8.1.1 Asia Pacific Preventive Asthma Drug Sales by Region
8.1.2 Asia Pacific Preventive Asthma Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Preventive Asthma Drug Market Facts & Figures by Type
8.3 Asia Pacific Preventive Asthma Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Preventive Asthma Drug by Country
9.1.1 Latin America Preventive Asthma Drug Sales by Country
9.1.2 Latin America Preventive Asthma Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Preventive Asthma Drug Market Facts & Figures by Type
9.3 Central & South America Preventive Asthma Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Preventive Asthma Drug by Country
10.1.1 Middle East and Africa Preventive Asthma Drug Sales by Country
10.1.2 Middle East and Africa Preventive Asthma Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Preventive Asthma Drug Market Facts & Figures by Type
10.3 Middle East and Africa Preventive Asthma Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Xiaflex
11.1.1 Xiaflex Corporation Information
11.1.2 Xiaflex Description and Business Overview
11.1.3 Xiaflex Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Xiaflex Preventive Asthma Drug Products Offered
11.1.5 Xiaflex Related Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description and Business Overview
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG Preventive Asthma Drug Products Offered
11.2.5 Novartis AG Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description and Business Overview
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Preventive Asthma Drug Products Offered
11.3.5 Roche Related Developments
11.4 Molecular Insight Pharmaceuticals
11.4.1 Molecular Insight Pharmaceuticals Corporation Information
11.4.2 Molecular Insight Pharmaceuticals Description and Business Overview
11.4.3 Molecular Insight Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Molecular Insight Pharmaceuticals Preventive Asthma Drug Products Offered
11.4.5 Molecular Insight Pharmaceuticals Related Developments
11.5 Callisto Pharmaceuticals
11.5.1 Callisto Pharmaceuticals Corporation Information
11.5.2 Callisto Pharmaceuticals Description and Business Overview
11.5.3 Callisto Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Callisto Pharmaceuticals Preventive Asthma Drug Products Offered
11.5.5 Callisto Pharmaceuticals Related Developments
11.1 Xiaflex
11.1.1 Xiaflex Corporation Information
11.1.2 Xiaflex Description and Business Overview
11.1.3 Xiaflex Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Xiaflex Preventive Asthma Drug Products Offered
11.1.5 Xiaflex Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Preventive Asthma Drug Market Estimates and Projections by Region
12.1.1 Global Preventive Asthma Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Preventive Asthma Drug Revenue Forecast by Regions 2021-2026
12.2 North America Preventive Asthma Drug Market Size Forecast (2021-2026)
12.2.1 North America: Preventive Asthma Drug Sales Forecast (2021-2026)
12.2.2 North America: Preventive Asthma Drug Revenue Forecast (2021-2026)
12.2.3 North America: Preventive Asthma Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Preventive Asthma Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Preventive Asthma Drug Sales Forecast (2021-2026)
12.3.2 Europe: Preventive Asthma Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Preventive Asthma Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Preventive Asthma Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Preventive Asthma Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Preventive Asthma Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Preventive Asthma Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Preventive Asthma Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Preventive Asthma Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Preventive Asthma Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Preventive Asthma Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Preventive Asthma Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Preventive Asthma Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Preventive Asthma Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Preventive Asthma Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Preventive Asthma Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Preventive Asthma Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Preventive Asthma Drug Market Segments
Table 2. Ranking of Global Top Preventive Asthma Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Preventive Asthma Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Somatostatin Analogs
Table 5. Major Manufacturers of Targeted Therapy
Table 6. Major Manufacturers of Chemotherapy
Table 7. Global Preventive Asthma Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Preventive Asthma Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Preventive Asthma Drug Sales by Regions 2015-2020 (K Units)
Table 10. Global Preventive Asthma Drug Sales Market Share by Regions (2015-2020)
Table 11. Global Preventive Asthma Drug Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Preventive Asthma Drug Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Preventive Asthma Drug Sales Share by Manufacturers (2015-2020)
Table 14. Global Preventive Asthma Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Preventive Asthma Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventive Asthma Drug as of 2019)
Table 16. Preventive Asthma Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Preventive Asthma Drug Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Preventive Asthma Drug Price (2015-2020) (USD/Unit)
Table 19. Preventive Asthma Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Preventive Asthma Drug Product Type
Table 21. Date of International Manufacturers Enter into Preventive Asthma Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Preventive Asthma Drug Sales by Type (2015-2020) (K Units)
Table 24. Global Preventive Asthma Drug Sales Share by Type (2015-2020)
Table 25. Global Preventive Asthma Drug Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Preventive Asthma Drug Revenue Share by Type (2015-2020)
Table 27. Preventive Asthma Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Preventive Asthma Drug Sales by Application (2015-2020) (K Units)
Table 29. Global Preventive Asthma Drug Sales Share by Application (2015-2020)
Table 30. North America Preventive Asthma Drug Sales by Country (2015-2020) (K Units)
Table 31. North America Preventive Asthma Drug Sales Market Share by Country (2015-2020)
Table 32. North America Preventive Asthma Drug Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Preventive Asthma Drug Revenue Market Share by Country (2015-2020)
Table 34. North America Preventive Asthma Drug Sales by Type (2015-2020) (K Units)
Table 35. North America Preventive Asthma Drug Sales Market Share by Type (2015-2020)
Table 36. North America Preventive Asthma Drug Sales by Application (2015-2020) (K Units)
Table 37. North America Preventive Asthma Drug Sales Market Share by Application (2015-2020)
Table 38. Europe Preventive Asthma Drug Sales by Country (2015-2020) (K Units)
Table 39. Europe Preventive Asthma Drug Sales Market Share by Country (2015-2020)
Table 40. Europe Preventive Asthma Drug Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Preventive Asthma Drug Revenue Market Share by Country (2015-2020)
Table 42. Europe Preventive Asthma Drug Sales by Type (2015-2020) (K Units)
Table 43. Europe Preventive Asthma Drug Sales Market Share by Type (2015-2020)
Table 44. Europe Preventive Asthma Drug Sales by Application (2015-2020) (K Units)
Table 45. Europe Preventive Asthma Drug Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Preventive Asthma Drug Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Preventive Asthma Drug Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Preventive Asthma Drug Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Preventive Asthma Drug Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Preventive Asthma Drug Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Preventive Asthma Drug Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Preventive Asthma Drug Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Preventive Asthma Drug Sales Market Share by Application (2015-2020)
Table 54. Latin America Preventive Asthma Drug Sales by Country (2015-2020) (K Units)
Table 55. Latin America Preventive Asthma Drug Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Preventive Asthma Drug Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Preventive Asthma Drug Revenue Market Share by Country (2015-2020)
Table 58. Latin America Preventive Asthma Drug Sales by Type (2015-2020) (K Units)
Table 59. Latin America Preventive Asthma Drug Sales Market Share by Type (2015-2020)
Table 60. Latin America Preventive Asthma Drug Sales by Application (2015-2020) (K Units)
Table 61. Latin America Preventive Asthma Drug Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Preventive Asthma Drug Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Preventive Asthma Drug Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Preventive Asthma Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Preventive Asthma Drug Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Preventive Asthma Drug Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Preventive Asthma Drug Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Preventive Asthma Drug Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Preventive Asthma Drug Sales Market Share by Application (2015-2020)
Table 70. Xiaflex Corporation Information
Table 71. Xiaflex Description and Major Businesses
Table 72. Xiaflex Preventive Asthma Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Xiaflex Product
Table 74. Xiaflex Recent Development
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Major Businesses
Table 77. Novartis AG Preventive Asthma Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novartis AG Product
Table 79. Novartis AG Recent Development
Table 80. Roche Corporation Information
Table 81. Roche Description and Major Businesses
Table 82. Roche Preventive Asthma Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Roche Product
Table 84. Roche Recent Development
Table 85. Molecular Insight Pharmaceuticals Corporation Information
Table 86. Molecular Insight Pharmaceuticals Description and Major Businesses
Table 87. Molecular Insight Pharmaceuticals Preventive Asthma Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Molecular Insight Pharmaceuticals Product
Table 89. Molecular Insight Pharmaceuticals Recent Development
Table 90. Callisto Pharmaceuticals Corporation Information
Table 91. Callisto Pharmaceuticals Description and Major Businesses
Table 92. Callisto Pharmaceuticals Preventive Asthma Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Callisto Pharmaceuticals Product
Table 94. Callisto Pharmaceuticals Recent Development
Table 95. Global Preventive Asthma Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 96. Global Preventive Asthma Drug Sales Market Share Forecast by Regions (2021-2026)
Table 97. Global Preventive Asthma Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 98. Global Preventive Asthma Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 99. North America: Preventive Asthma Drug Sales Forecast by Country (2021-2026) (K Units)
Table 100. North America: Preventive Asthma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Europe: Preventive Asthma Drug Sales Forecast by Country (2021-2026) (K Units)
Table 102. Europe: Preventive Asthma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Asia Pacific: Preventive Asthma Drug Sales Forecast by Region (2021-2026) (K Units)
Table 104. Asia Pacific: Preventive Asthma Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 105. Latin America: Preventive Asthma Drug Sales Forecast by Country (2021-2026) (K Units)
Table 106. Latin America: Preventive Asthma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Middle East and Africa: Preventive Asthma Drug Sales Forecast by Country (2021-2026) (K Units)
Table 108. Middle East and Africa: Preventive Asthma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 110. Key Challenges
Table 111. Market Risks
Table 112. Main Points Interviewed from Key Preventive Asthma Drug Players
Table 113. Preventive Asthma Drug Customers List
Table 114. Preventive Asthma Drug Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Preventive Asthma Drug Product Picture
Figure 2. Global Preventive Asthma Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Somatostatin Analogs Product Picture
Figure 4. Targeted Therapy Product Picture
Figure 5. Chemotherapy Product Picture
Figure 6. Global Preventive Asthma Drug Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinics
Figure 9. Oncology Centres
Figure 10. Preventive Asthma Drug Report Years Considered
Figure 11. Global Preventive Asthma Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Preventive Asthma Drug Sales 2015-2026 (K Units)
Figure 13. Global Preventive Asthma Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Preventive Asthma Drug Sales Market Share by Region (2015-2020)
Figure 15. Global Preventive Asthma Drug Sales Market Share by Region in 2019
Figure 16. Global Preventive Asthma Drug Revenue Market Share by Region (2015-2020)
Figure 17. Global Preventive Asthma Drug Revenue Market Share by Region in 2019
Figure 18. Global Preventive Asthma Drug Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Preventive Asthma Drug Revenue in 2019
Figure 20. Preventive Asthma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Preventive Asthma Drug Sales Market Share by Type (2015-2020)
Figure 22. Global Preventive Asthma Drug Sales Market Share by Type in 2019
Figure 23. Global Preventive Asthma Drug Revenue Market Share by Type (2015-2020)
Figure 24. Global Preventive Asthma Drug Revenue Market Share by Type in 2019
Figure 25. Global Preventive Asthma Drug Market Share by Price Range (2015-2020)
Figure 26. Global Preventive Asthma Drug Sales Market Share by Application (2015-2020)
Figure 27. Global Preventive Asthma Drug Sales Market Share by Application in 2019
Figure 28. Global Preventive Asthma Drug Revenue Market Share by Application (2015-2020)
Figure 29. Global Preventive Asthma Drug Revenue Market Share by Application in 2019
Figure 30. North America Preventive Asthma Drug Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Preventive Asthma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Preventive Asthma Drug Sales Market Share by Country in 2019
Figure 33. North America Preventive Asthma Drug Revenue Market Share by Country in 2019
Figure 34. U.S. Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Preventive Asthma Drug Market Share by Type in 2019
Figure 39. North America Preventive Asthma Drug Market Share by Application in 2019
Figure 40. Europe Preventive Asthma Drug Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Preventive Asthma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Preventive Asthma Drug Sales Market Share by Country in 2019
Figure 43. Europe Preventive Asthma Drug Revenue Market Share by Country in 2019
Figure 44. Germany Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Preventive Asthma Drug Market Share by Type in 2019
Figure 55. Europe Preventive Asthma Drug Market Share by Application in 2019
Figure 56. Asia Pacific Preventive Asthma Drug Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Preventive Asthma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Preventive Asthma Drug Sales Market Share by Region in 2019
Figure 59. Asia Pacific Preventive Asthma Drug Revenue Market Share by Region in 2019
Figure 60. China Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Preventive Asthma Drug Market Share by Type in 2019
Figure 83. Asia Pacific Preventive Asthma Drug Market Share by Application in 2019
Figure 84. Latin America Preventive Asthma Drug Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Preventive Asthma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Preventive Asthma Drug Sales Market Share by Country in 2019
Figure 87. Latin America Preventive Asthma Drug Revenue Market Share by Country in 2019
Figure 88. Mexico Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Preventive Asthma Drug Market Share by Type in 2019
Figure 95. Latin America Preventive Asthma Drug Market Share by Application in 2019
Figure 96. Middle East and Africa Preventive Asthma Drug Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Preventive Asthma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Preventive Asthma Drug Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Preventive Asthma Drug Revenue Market Share by Country in 2019
Figure 100. Turkey Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Preventive Asthma Drug Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Preventive Asthma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Preventive Asthma Drug Market Share by Type in 2019
Figure 107. Middle East and Africa Preventive Asthma Drug Market Share by Application in 2019
Figure 108. North America Preventive Asthma Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Preventive Asthma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Preventive Asthma Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Preventive Asthma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Preventive Asthma Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Preventive Asthma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Preventive Asthma Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Preventive Asthma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Preventive Asthma Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Preventive Asthma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
オンサイト予防ケアの世界市場（～2026年） On-site preventive care provides administrations with treatment options for their employees and representative services pertaining to healthcare in their work place. These on-site services tend to diminish the rate of services used by the employees on off-site preventive care. The services that are …- 歯科用予防用品の世界市場（～2026年） Dental Preventive Supplies are used to keep your teeth healthy. Dental preventive products market is significantly influenced by the economic environment, socioeconomic background of patients, and discretionary spending levels. Growth in the market is driven by the increasing risk of dental caries a…
- 好酸球性喘息治療の世界市場（～2026年） Eosinophilic asthma is a form of asthma categorized by greater levels of eosinophils in the air passages. Eosinophilic Asthma Treatment market is driven by increasing pollution and lowering immunity in the population. Susceptibility of allergies within individuals has increased resulting in the incr…
- 喘息ケア機器の世界市場（～2026年） Asthma is a common chronic disease among children which worsens with age. Asthma is a complex inflammatory disease projected to be caused by genetic mutation or other environmental factors. Asthma attack can be lethal if not addressed or treated on time.Health monitoring of asthma patients and track…
- 喘息・COPDの世界市場（～2026年） Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway. Asthma is usually considered a sepa…